Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls
Abstract Background Metformin, a medication for type 2 diabetes, has been linked to many non-diabetes health benefits including increasing healthy lifespan. Previous work has only examined the benefits of metformin over periods of less than ten years, which may not be long enough to capture the true...
Main Authors: | Joshua Stevenson-Hoare, Ganna Leonenko, Valentina Escott-Price |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-023-15764-y |
Similar Items
-
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients
by: Adiel Ortega-Ayala, et al.
Published: (2022-06-01) -
Single Nucleotide Polymorphisms Associated with Metformin and Sulphonylureas’ Glycaemic Response among South African Adults with Type 2 Diabetes Mellitus
by: Charity Masilela, et al.
Published: (2021-02-01) -
Screening of individuals with type 2 diabetes on anti-diabetic agents for probable hypoglycaemia using the stanford hypoglycemia questionnaire (SHQ) in outpatient settings: A cross-sectional study from outpatient diabetes care centres in North India
by: Rajiv Awasthi, et al.
Published: (2024-01-01) -
Successful transition to sulphonylurea therapy from insulin in a child with permanent neonatal diabetes due to a KCNJ11 gene mutation
by: Venkatesan Radha, et al.
Published: (2018-01-01) -
Are Alzheimer's and coronary artery diseases genetically related to longevity?
by: Eftychia Bellou, et al.
Published: (2023-01-01)